Literature DB >> 24745770

Immunohistochemical evaluation of tissue factor, fibrin/fibrinogen and D-dimers in canine gliomas.

Cristian de la Fuente1, Martí Pumarola2, Ester Blasco2, Francisco Fernández2, Judit Viu1, Sònia Añor3.   

Abstract

In human gliomas, tissue factor (TF) is overexpressed, associated with the grade of malignancy and influences tumour biology. Intra-tumoural fibrin/fibrinogen deposition and activation of the fibrinolytic system also play a role in tumour cell proliferation and angiogenesis. The first aim of the present study was to investigate TF expression and the presence of fibrin/fibrinogen and D-dimers in canine glioma biopsies, graded according to the World Health Organization (WHO) classification of tumours of the central nervous system. The second aim was to investigate the occurrence of intravascular thrombosis (IVT) in canine gliomas, as a potential histological marker of glioma type or grade of malignancy. An immunohistochemical study using antibodies against TF, fibrin/fibrinogen and D-dimers was performed with 24 glioma samples, including 15 oligodendrogliomas, 6 astrocytomas and 3 mixed gliomas. Immunohistochemical data were statistically analysed to determine whether there was any relationship between glioma type and grade of malignancy. All gliomas were moderate to strongly positive for TF and the staining score was significantly higher (P = 0.04) in high-grade (III or IV) than in low-grade (II) gliomas. Intra-tumoural fibrin/fibrinogen deposition was detected in all tumour biopsies assessed, and D-dimers were detected in 17/24 gliomas. IVT was a frequent finding, but was not linked to a specific glioma type or malignancy grade. TF expression, fibrin/fibrinogen deposition, extravascular fibrinolytic system activation and IVT occur in canine gliomas. Canine glioma might be a suitable model for studying coagulation and fibrinolysis as potential therapeutic targets for human gliomas.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Astrocytoma; Coagulation; Fibrinolysis; Immunohistochemistry; Oligodendroglioma

Mesh:

Substances:

Year:  2014        PMID: 24745770     DOI: 10.1016/j.tvjl.2014.03.021

Source DB:  PubMed          Journal:  Vet J        ISSN: 1090-0233            Impact factor:   2.688


  3 in total

1.  Evaluation of procoagulant tissue factor expression in canine hemangiosarcoma cell lines.

Authors:  Lauren E Witter; Erika J Gruber; Fabian Z X Lean; Tracy Stokol
Journal:  Am J Vet Res       Date:  2017-01       Impact factor: 1.156

2.  Tissue factor procoagulant activity in the tumor cell lines and plasma of dogs with various malignant tumors.

Authors:  Kosuke Kobayashi; Kenji Baba; Masaya Igase; Hardany Primarizky; Yuki Nemoto; Takako Shimokawa Miyama; Satoshi Kambayashi; Takuya Mizuno; Masaru Okuda
Journal:  J Vet Med Sci       Date:  2019-10-15       Impact factor: 1.267

3.  Evaluation of different commercial antibodies for their ability to detect human and mouse tissue factor by western blotting.

Authors:  Axel Rosell; Bernhard Moser; Yohei Hisada; Rukesh Chinthapatla; Grace Lian; Yi Yang; Matthew J Flick; Nigel Mackman
Journal:  Res Pract Thromb Haemost       Date:  2020-07-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.